Edward F. Patz, Jr

Company: Grid Therapeutics, Duke University School of Medicine

Job title: CEO & James and Alice Chen Distinguished Professor of Radiology, Pharmacology & Cancer Biology

Seminars:

Complement as a Natural Adjuvant to Promote Anti-Tumor Immunity in Cancer Therapy 12:00 pm

Exploring how the complement system interacts with the tumor microenvironment in driving anti-tumor immunity in cancer Human-derived antibodies can cause complement activation, tumor-specific cytotoxicity, and anti-tumor immunity Evaluating implications for metrics in measuring success of complement therapy in cancer, and subsequent novel trial designRead more

day: Day Two